HELENA MENDIN: Open Payments
NPI 1043793847 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$171 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $57 · 2025 $171
Food & beverage: $171
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $52 |
| ABBVIE INC. | 1 | $34 |
| Alkermes, Inc. | 1 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
Products named: INGREZZA, VRAYLAR, LYBALVI, CAPLYTA, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
